المؤلفون: Ilya Tsimafeyeu, Vyacheslav Chubenko, Olga Baklanova, Alexey Kalpinskiy, Sufia Safina, Andrei Lebedinets, Vladislav Petkau, Elvira Parsadanova, Maria Turganova, Aleksei Shkurat, Natalia Tovbik, Elena Tkacheva, Yulia Anzhiganova, Olga Novikova, Varvara Bragina, Ruslan Zukov, Rashida Orlova

المصدر: Current Oncology, Vol 32, Iss 1, p 11 (2024)

مصطلحات موضوعية: avelumab plus axitinib, first-line therapy, metastatic renal cell carcinoma, RAVE-Renal ambispective study, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://www.mdpi.com/1718-7729/32/1/11; https://doaj.org/toc/1198-0052; https://doaj.org/toc/1718-7729

URL الوصول: https://doaj.org/article/7ecd1bd6e5b545dc8c096c9e48ae78ec

المؤلفون: Grimm, Marc-Oliver, Oya, Mototsugu, Choueiri, Toni K, Motzer, Robert J, Schmidinger, Manuela, Quinn, David I, Gravis-Mescam, Gwenaelle, Verzoni, Elena, Van den Eertwegh, Alfonsus J M, di Pietro, Alessandra, Mariani, Mariangela, Wang, Jing, Thomaidou, Despina, Albiges, Laurence

مصطلحات موضوعية: article, ScholarlyArticle, ddc:610, Kidney, Humans, Carcinoma, Renal Cell, Kidney Neoplasms, Nephrectomy, Prospective Studies, Cytoreduction Surgical Procedures, Sunitinib, Axitinib, Renal cell carcinoma, Synchronous Metastases, Avelumab Plus Axitinib

وصف الملف: 5 Seiten

Relation: European urology -- 1873-7560; https://doi.org/10.1016/j.eururo.2023.09.016

الاتاحة: https://doi.org/10.1016/j.eururo.2023.09.016
https://nbn-resolving.org/urn:nbn:de:gbv:27-dbt-20240419-154352-004
https://www.db-thueringen.de/receive/dbt_mods_00060434
https://www.db-thueringen.de/servlets/MCRFileNodeServlet/dbt_derivate_00063018/1-s2.0-S0302283823031433-main.pdf

المساهمون: G Galffy, I Lugowska, E V Poddubskaya, B C Cho, M-J Ahn, J-Y Han, W-C Su, R J Hauke, S H Dyar, D H Lee, P Serwatowski, D L Estelles, V R Holden, Y J Kim, V Vladimirov, Z Horvath, A Ghose, A Goldman, A di Pietro, J Wang, D A Murphy, A Alhadab, M Laskov, Cho, Byoung Chul

مصطلحات موضوعية: Antibodies, Monoclonal / adverse effects, Axitinib / pharmacology, Axitinib / therapeutic use, Carcinoma, Non-Small-Cell Lung* / drug therapy, Non-Small-Cell Lung* / pathology, Transitional Cell, Cisplatin / pharmacology, Cisplatin / therapeutic use, Humans, Lung Neoplasms* / drug therapy, Lung Neoplasms* / pathology, Urinary Bladder Neoplasms, avelumab plus axitinib, immune checkpoint inhibitor, non-small-cell lung cancer, urothelial carcinoma

Relation: ESMO OPEN; J03799; OAK-2023-02583; https://ir.ymlib.yonsei.ac.kr/handle/22282913/196061; T202304518; ESMO OPEN, Vol.8(3) : 101173, 2023-06

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/196061
https://doi.org/10.1016/j.esmoop.2023.101173

المؤلفون: Ayano Uekawa, Ryoma Kurahashi, Takanobu Motoshima, Yoji Murakami, Junji Yatsuda, Tomomi Kamba

المصدر: Urology Case Reports, Vol 45, Iss , Pp 102198- (2022)

مصطلحات موضوعية: Metastatic renal cell carcinoma, Avelumab plus axitinib, Late line, IO-TKI combo, Combination therapy, Diseases of the genitourinary system. Urology, RC870-923

وصف الملف: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2214442022002108; https://doaj.org/toc/2214-4420

URL الوصول: https://doaj.org/article/ec9d52d6feeb475fa401f192d6f7bc69